Oral treatment with HE3286 ameliorates disease in rodent models of rheumatoid arthritis.
Saved in:
| Title: | Oral treatment with HE3286 ameliorates disease in rodent models of rheumatoid arthritis. |
|---|---|
| Authors: | Auci DL; HollisEden Pharmaceuticals, San Diego, CA, USA., Mangano K, Destiche D, White SK, Huang Y, Boyle D, Frincke J, Reading CL, Nicoletti F |
| Source: | International journal of molecular medicine [Int J Mol Med] 2010 Apr; Vol. 25 (4), pp. 625-33. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9810955 Publication Model: Print Cited Medium: Internet ISSN: 1791-244X (Electronic) Linking ISSN: 11073756 NLM ISO Abbreviation: Int J Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
